Evidence that hydrogen sulfide is a genotoxic agent

Molecular Cancer Research

Volumn 4, Issue 1, 2006, Pages 9-14

  Attene Ramos, Matias S ^a   Wagner, Elizabeth D ^a   Plewa, Michael J ^a   Gaskins, H Rex ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROGEN SULFIDE;

ANIMAL CELL; ARTICLE; CELL LINE; CHO CELL; COLORECTAL CANCER; COMET ASSAY; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; GENOTOXICITY; NONHUMAN; PRIORITY JOURNAL; STANDARD;

ANIMALS; CELL NUCLEUS; CHO CELLS; COMET ASSAY; CRICETINAE; DNA DAMAGE; GENOME; HT29 CELLS; HUMANS; HYDROGEN SULFIDE; HYDROXYUREA; MUTAGENS;

ANIMALIA; CRICETULUS GRISEUS;

EID: 32944457229     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-05-0126     Document Type: Article

References (62)

1. Weitz J, Koch M, Debus J, Hohler T, Galle PR, Buchler MW. Colorectal cancer. Lancet 2005;365:153-65.
2. Potter JD. Colorectal cancer: molecules and populations. J Natl Cancer Inst 1999;91:916-32.
3. Rhodes JM, Campbell BJ. Inflammation and colorectal cancer: IBD-associated and sporadic cancer compared. Trends Mol Med 2002;8:10-6.
4. de la Chapelle A. Genetic predisposition to colorectal cancer. Nat Rev Cancer 2004;4:769-80.
5. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996;87:159-70.
6. Stoler DL, Chen N, Basik M, et al. The onset and extent of genomic instability in sporadic colorectal tumor progression. Proc Natl Acad Sci U S A 1999;96:15121-6.
7. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57-70.
8. Shih IM, Zhou W, Goodman SN, Lengauer C, Kinzler KW, Vogelstein B. Evidence that genetic instability occurs at an early stage of colorectal tumorigenesis. Cancer Res 2001;61:818-22.
9. Lindblom A. Different mechanisms in the tumorigenesis of proximal and distal colon cancers. Curr Opin Oncol 2001;13:63-9.
10. Breivik J, Gaudernack G. Genomic instability, DNA methylation, and natural selection in colorectal carcinogenesis. Semin Cancer Biol 1999;9:245-54.
11. Babbs CF. Free radicals and the etiology of colon cancer. Free Radic Biol Med 1990;8:191-200.
12. Duesberg P, Rausch C, Rasnick D, Hehlmann R. Genetic instability of cancer cells is proportional to their degree of aneuploidy. Proc Natl Acad Sci U S A 1998;95:13692-7.
13. Huycke MM, Abrams V, Moore DR. Enterococcus faecalis produces extracellular superoxide and hydrogen peroxide that damages colonic epithelial cell DNA. Carcinogenesis 2002;23:529-36.
14. Thiagalingam S, Laken S, Willson JK, et al. Mechanisms underlying losses of heterozygosity in human colorectal cancers. Proc Natl Acad Sci U S A 2001;98:2698-702.
15. Gibson GR, Cummings JH, Macfarlane GT. Growth and activities of sulphate-reducing bacteria in gut contents of healthy subjects and patients with ulcerative colitis. FEMS Microbiol Lett 1991;86:103-11.
16. Pitcher MCL, Beatty ER, Gibson GR, Cummings JH. Incidence and activities of sulphate-reducing bacteria in patients with ulcerative colitis. Gut 1995;36:A63.
17. Kanazawa K, Konishi F, Mitsuoka T, et al. Factors influencing the development of sigmoid colon cancer. Bacteriologic and biochemical studies. Cancer 1996;77:1701-6.
18. Roediger WE, Moore J, Babidge W. Colonic sulfide in pathogenesis and treatment of ulcerative colitis. Dig Dis Sci 1997;42:1571-9.
19. Levitt MD, Furne J, Springfield J, Suarez F, DeMaster E. Detoxification of hydrogen sulfide and methanethiol in the cecal mucosa. J Clin Invest 1999;104:1107-14.
20. Moore J, Babidge W, Millard S, Roediger W. Colonic luminal hydrogen sulfide is not elevated in ulcerative colitis. Dig Dis Sci 1998;43:162-5.
21. Babidge W, Millard S, Roediger W. Sulfides impair short chain fatty acid β-oxidation at acyl-CoA dehydrogenase level in colonocytes: implications for ulcerative colitis. Mol Cell Biochem 1998;181:117-24.
22. Roediger WE, Duncan A, Kapaniris O, Millard S. Reducing sulfur compounds of the colon impair colonocyte nutrition: implications for ulcerative colitis. Gastroenterology 1993;104:802-9.
23. Christi SU, Eisner HD, Dusel G, Kasper H, Scheppach W. Antagonistic effects of sulfide and butyrate on proliferation of colonic mucosa: a potential role for these agents in the pathogenesis of ulcerative colitis. Dig Dis Sci 1996;41:2477-81.
24. Deplancke B, Gaskins HR. Hydrogen sulfide induces serum-independent cell cycle entry in nontransformed rat intestinal epithelial cells. FASEB J 2003;17:1310-2.
25. Roediger WE, Duncan A, Kapaniris O, Millard S. Sulphide impairment of substrate oxidation in rat colonocytes: a biochemical basis for ulcerative colitis? Clin Sci (Lond) 1993;85:623-7.
26. Moore JW, Millard S, Babidge W, Rowland R, Roediger WE. Hydrogen sulphide produces diminished fatty acid oxidation in the rat colon in vivo: implications for ulcerative colitis. Aust N Z J Surg 1997;67:245-9.
27. Huycke MM, Gaskins HR. Commensal bacteria, redox stress, and colorectal cancer: mechanisms and models. Exp Biol Med 2004;229:586-97.
28. Leschelle X, Goubern M, Andriamihaja M, et al. Adaptative metabolic response of human colonic epithelial cells to the adverse effects of the luminal compound sulfide. Biochim Biophys Acta 2005;1725:201-12.
29. Chou S, Bitter P, Longstreth J. Toxicological profile for hydrogen sulfide. Atlanta (GA): U.S. Department of Health and Human Services, Public Health Service, Agency for Toxic Substances and Disease Registry; 1999.
30. Plewa MJ, Kargalioglu Y, Vankerk D, Minear RA, Wagner ED. Development of a quantitative comparative cytotoxicity and genotoxicity assays for environmental hazardous chemicals. Water Sci Technol 2000;42:109-16.
31. Plewa MJ, Kargalioglu Y, Vankerk D, Minear RA, Wagner ED. Mammalian cell cytotoxicity and genotoxicity analysis of drinking water disinfection by-products. Environ Mol Mutagen 2002;40:134-42.
32. Plewa MJ, Wagner ED, Jazwierska P, Richardson SD, Chen PH, McKague AB. Halonitromethane drinking water disinfection byproducts: chemical characterization and mammalian cell cytotoxicity and genotoxicity. Environ Sci Technol 2004;38:62-8.
33. Deplancke B, Finster K, Graham WV, Collier CT, Thurmond JE, Gaskins HR. Gastrointestinal and microbial responses to sulfate-supplemented drinking water in mice. Exp Biol Med 2003;228:424-33.
34. Florin T, Neale G, Gibson GR, Christl SU, Cummings JH. Metabolism of dietary sulphate: absorption and excretion in humans. Gut 1991;32:766-73.
35. Pochart P, Dore J, Lemann F, Goderel I, Rambaud JC. Interrelations between populations of methanogenic archaea and sulfate-reducing bacteria in the human colon. FEMS Microbiol Lett 1992;77:225-8.
36. Magee EA, Richardson CJ, Hughes R, Cummings JH. Contribution of dietary protein to sulfide production in the large intestine: an in vitro and a controlled feeding study in humans. Am J Clin Nutr 2000;72:1488-94.
37. Picton R, Eggo MC, Merrill GA, Langman MJ, Singh S. Mucosal protection against sulphide: importance of the enzyme rhodanese. Gut 2002;50:201-5.
38. Powell MA, Somero GN. Hydrogen-sulfide oxidation is coupled to oxidative-phosphorylation in mitochondria of Solemya reidi. Science 1986;233:563-6.
39. Skoog L, Nordenskjold B. Effects of hydroxyurea and 1-β-D- arabinofuranosyl-cytosine on deoxyribonucleotide pools in mouse embryo cells. Eur J Biochem 1971;19:81-9.
40. Thelander L, Reichard P. Reduction of ribonucleotides. Annu Rev Biochem 1979;48:133-58.
41. Severin I, Padieu M, Lhuguenot JC, Chagnon MC. Toxic interaction between hydroxyurea and 1-β-D-arabino-furanosylcytosine on the DNA of a human hepatoma cell line (HEPG2). Toxicol Lett 2003;145:303-11.
42. Augeron C, Laboisse CL. Emergence of permanently differentiated cell clones in a human colonic cancer cell line in culture after treatment with sodium butyrate. Cancer Res 1984;44:3961-9.
43. Hughes TJ, Sparacino C, Frazier S. Validation of chemical and biological techniques for evaluation of vapors in ambient air testing of twelve (12) vapor-phase compounds (project summary). Research Triangle Park (NC): Environmental Protection Agency; 1984.
44. Berglin EH, Carlsson J. Effect of hydrogen sulfide on the mutagenicity of hydrogen peroxide in Salmonella typhimurium strain TA102. Mutat Res 1986;175:5-9.
45. Moore DM, Kotake Y, Huycke MM. Enterococcus faecalis produces thiyl radicals while colonizing the colon. Free Radic Biol Med 2003;35:5175.
46. Derijard B, Hibi M, Wu IH, et al. JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 1994;76:1025-37.
47. Shaulian E, Karin M. AP-1 in cell proliferation and survival. Oncogene 2001;20:2390-400.
48. Hayakawa J, Mittal S, Wang Y, et al. Identification of promoters bound by c-Jun/ATF2 during rapid large-scale gene activation following genotoxic stress. Mol Cell 2004;16:521-35.
49. Hoeijmakers JH. Genome maintenance mechanisms for preventing cancer. Nature 2001;411:366-74.
50. Jackson SP. Sensing and repairing DNA double-strand breaks. Carcinogenesis 2002;23:687-96.
51. Khanna KK, Jackson SP. DNA double-strand breaks: signaling, repair and the cancer connection. Nat Genet 2001;27:247-54.
52. Ierardi E, Principi M, Francavilla R, et al. Epithelial proliferation and ras p21 oncoprotein expression in rectal mucosa of patients with ulcerative colitis. Dig Dis Sci 2001;46:1083-7.
53. Shen MR, Jones IM, Mohrenweiser H. Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res 1998;58:604-8.
54. Goode EL, Ulrich CM, Potter JD. Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev 2002;11:1513-30.
55. 399Gln variant alleles of the DNA repair gene XRCC1 are associated with increased risk of early-onset colorectal carcinoma in Egypt. Cancer Lett 2000;159:79-86.
56. Yeh CC, Hsieh LL, Tang R, Chang-Chieh CR, Sung FC. MS-920: DNA repair gene polymorphisms, diet and colorectal cancer risk in Taiwan. Cancer Lett 2005;224:279-88.
57. Yeh CC, Sung FC, Tang R, Chang-Chieh CR, Hsieh LL. Polymorphisms of the XRCC1, XRCC3, & XPD genes, and colorectal cancer risk: a case-control study in Taiwan. BMC Cancer 2005;5:12.
58. Mort R, Mo L, McEwan C, Melton DW. Lack of involvement of nucleotide excision repair gene polymorphisms in colorectal cancer. Br J Cancer 2003;89:333-7.
59. Baglioni S, Genuardi M. Simple and complex genetics of colorectal cancer susceptibility. Am J Med Genet C Semin Med Genet 2004;129:35-43.
60. Al-Tassan N, Chmiel NH, Maynard J, et al. Inherited variants of MYH associated with somatic G:C->T:A mutations in colorectal tumors. Nat Genet 2002;30:227-32.
61. Wagner ED, Rayburn AL, Anderson D, Plewa MJ. Analysis of mutagens with single cell gel electrophoresis, flow cytometry, and forward mutation assays in an isolated clone of Chinese hamster ovary cells. Environ Mol Mutagen 1998;32:360-8.
62. Lovell DP, Thomas G, Dubow R. Issues related to the experimental design and subsequent statistical analysis of in vivo and in vitro comet studies. Teratog Carcinog Mutegen 1999;19:109-19.